Impact of obesity on uteroplacental immunology and placental pathology

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Obesity is a growing problem. Currently 1 in 3 reproductive-age women is obese. This is significant because obesity is associated with an increased risk of gestational diabetesmellitus (GDM), pretermbirth, fetal growth abnormalities, preeclampsia, and stillbirth. Obesity alone increases the risk of stillbirth by threefold, whereas GDM increases this risk to approximately 10-fold. How obesity and GDM affect placental and fetal growth are beginning to be understood, but the underlying pathophysiology leading to bad pregnancy outcomes is essentially unknown. This review will discuss the effects of obesity and GDM on fetoplacental growth, the histopathologic features seen in these placentas, how obesity may affect uterine spiral artery remodeling, and why this leads to placental insufficiency. New insights suggest that abnormal regulation of maternal T cells and uterine natural killer cells may be important in the disease process, but much more research is needed.

Original languageEnglish (US)
Pages (from-to)e70-e79
JournalNeoReviews
Volume17
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Allergy and Immunology
Obesity
Pathology
Stillbirth
Fetal Development
Placental Insufficiency
Uterine Artery
Pregnancy Outcome
Pre-Eclampsia
Natural Killer Cells
Placenta
Mothers
T-Lymphocytes
Growth
Research

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Impact of obesity on uteroplacental immunology and placental pathology. / Morgan, Terry.

In: NeoReviews, Vol. 17, No. 2, 01.02.2016, p. e70-e79.

Research output: Contribution to journalArticle

@article{da2593afe4e8409ca0b8228353019bf7,
title = "Impact of obesity on uteroplacental immunology and placental pathology",
abstract = "Obesity is a growing problem. Currently 1 in 3 reproductive-age women is obese. This is significant because obesity is associated with an increased risk of gestational diabetesmellitus (GDM), pretermbirth, fetal growth abnormalities, preeclampsia, and stillbirth. Obesity alone increases the risk of stillbirth by threefold, whereas GDM increases this risk to approximately 10-fold. How obesity and GDM affect placental and fetal growth are beginning to be understood, but the underlying pathophysiology leading to bad pregnancy outcomes is essentially unknown. This review will discuss the effects of obesity and GDM on fetoplacental growth, the histopathologic features seen in these placentas, how obesity may affect uterine spiral artery remodeling, and why this leads to placental insufficiency. New insights suggest that abnormal regulation of maternal T cells and uterine natural killer cells may be important in the disease process, but much more research is needed.",
author = "Terry Morgan",
year = "2016",
month = "2",
day = "1",
doi = "10.1542/neo.17-2-e70",
language = "English (US)",
volume = "17",
pages = "e70--e79",
journal = "NeoReviews",
issn = "1526-9906",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - Impact of obesity on uteroplacental immunology and placental pathology

AU - Morgan, Terry

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Obesity is a growing problem. Currently 1 in 3 reproductive-age women is obese. This is significant because obesity is associated with an increased risk of gestational diabetesmellitus (GDM), pretermbirth, fetal growth abnormalities, preeclampsia, and stillbirth. Obesity alone increases the risk of stillbirth by threefold, whereas GDM increases this risk to approximately 10-fold. How obesity and GDM affect placental and fetal growth are beginning to be understood, but the underlying pathophysiology leading to bad pregnancy outcomes is essentially unknown. This review will discuss the effects of obesity and GDM on fetoplacental growth, the histopathologic features seen in these placentas, how obesity may affect uterine spiral artery remodeling, and why this leads to placental insufficiency. New insights suggest that abnormal regulation of maternal T cells and uterine natural killer cells may be important in the disease process, but much more research is needed.

AB - Obesity is a growing problem. Currently 1 in 3 reproductive-age women is obese. This is significant because obesity is associated with an increased risk of gestational diabetesmellitus (GDM), pretermbirth, fetal growth abnormalities, preeclampsia, and stillbirth. Obesity alone increases the risk of stillbirth by threefold, whereas GDM increases this risk to approximately 10-fold. How obesity and GDM affect placental and fetal growth are beginning to be understood, but the underlying pathophysiology leading to bad pregnancy outcomes is essentially unknown. This review will discuss the effects of obesity and GDM on fetoplacental growth, the histopathologic features seen in these placentas, how obesity may affect uterine spiral artery remodeling, and why this leads to placental insufficiency. New insights suggest that abnormal regulation of maternal T cells and uterine natural killer cells may be important in the disease process, but much more research is needed.

UR - http://www.scopus.com/inward/record.url?scp=84975728172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975728172&partnerID=8YFLogxK

U2 - 10.1542/neo.17-2-e70

DO - 10.1542/neo.17-2-e70

M3 - Article

VL - 17

SP - e70-e79

JO - NeoReviews

JF - NeoReviews

SN - 1526-9906

IS - 2

ER -